Multidrug resistance 3 (MDR3) protein and tacrine-induced hepatotoxicity

被引:0
|
作者
Alfirevic, Ana [1 ]
Carr, Daniel F. [1 ]
Mills, Tracy [1 ]
Hartkoorn, Ruben [1 ]
Owen, A. [1 ]
Tugwood, Jonathan D. [1 ]
Smith, John [1 ]
Park, Brian Kevin [1 ]
Pirmohamed, Munir [1 ]
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
246
引用
收藏
页码:173 / 173
页数:1
相关论文
共 50 条
  • [1] TACRINE-INDUCED HEPATOTOXICITY - TOLERABILITY AND MANAGEMENT
    BALSON, R
    GIBSON, PR
    AMES, D
    BHATHAL, PS
    CNS DRUGS, 1995, 4 (03) : 168 - 181
  • [2] Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals
    Aleo, Michael D.
    Shah, Falgun
    He, Kan
    Bonin, Paul D.
    Rodrigues, A. David
    CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (05) : 1219 - 1229
  • [3] OVEREXPRESSION OF THE MULTIDRUG RESISTANCE GENE MDR3 IN SPONTANEOUS AND CHEMICALLY-INDUCED MOUSE HEPATOCELLULAR CARCINOMAS
    TEETER, LD
    BECKER, FF
    CHISARI, FV
    LI, DJ
    KUO, MT
    MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) : 5728 - 5735
  • [4] Ursodeoxycholic acid and prevention of tacrine-induced hepatotoxicity: a pilot study
    Salmon, L
    Montet, JC
    Oddoze, C
    Montet, AM
    Portugal, H
    Michel, BF
    THERAPIE, 2001, 56 (01): : 29 - 34
  • [5] EXPRESSION OF MDR1 AND MDR3 MULTIDRUG-RESISTANCE GENES IN HAIRY-CELL LEUKEMIA
    HERWEIJER, H
    NOOTER, K
    BEISHUIZEN, A
    SONNEVELD, P
    OOSTRUM, RG
    HESSELINGJANSSEN, ALW
    VANDONGEN, JJM
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) : 297 - 298
  • [6] Molecular and genetic association of interleukin-6 in tacrine-induced hepatotoxicity
    Carr, Daniel F.
    Alfirevic, Ana
    Tugwood, Jonathan D.
    Barratt, Bryan J.
    Sherwood, James
    Smith, John
    Pirmohamed, Munir
    Park, B. Kevin
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (11): : 961 - 972
  • [7] MDR3 and disease
    Elferink, RO
    Eppens, E
    Pawlikowska, L
    Looije, N
    Mok, K
    DRUG METABOLISM REVIEWS, 2002, 34 : 39 - 39
  • [8] Investigating bile acid-mediated cholestatic drug-induced liver injury using a mechanistic model of multidrug resistance protein 3 (MDR3) inhibition
    Beaudoin, James J.
    Yang, Kyunghee
    Adiwidjaja, Jeffry
    Taneja, Guncha
    Watkins, Paul B.
    Siler, Scott Q.
    Howell, Brett A.
    Woodhead, Jeffrey L.
    FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [9] Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
    Hontecillas-Prieto, Lourdes
    Garcia-Dominguez, Daniel J.
    Pascual Vaca, Diego
    Garcia-Mejias, Rosa
    Marcilla, David
    Ramirez-Villar, Gema L.
    Saez, Carmen
    de Alava, Enrique
    ONCOTARGET, 2017, 8 (07) : 11173 - 11186
  • [10] Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals (vol 30, pg 1219, 2017)
    Aleo, Michael D.
    Shah, Falgun
    He, Kan
    Bonin, Paul D.
    Rodrigues, A. David
    CHEMICAL RESEARCH IN TOXICOLOGY, 2017, 30 (06) : 1365 - 1365